These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11721461)

  • 21. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth.
    Gómez Román JJ; Garay GO; Saenz P; Escuredo K; Sanz Ibayondo C; Gutkind S; Junquera C; Simón L; Martínez A; Fernández Luna JL; Val-Bernal JF
    Transl Res; 2008 Mar; 151(3):134-40. PubMed ID: 18279812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity and susceptibility to apoptosis of human renal carcinoma cells in vitro.
    Dell'Antonio G; Rovere P; Mangili F; Manfredi AA
    Eur J Histochem; 1998; 42(4):327-32. PubMed ID: 10068906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
    Shimabukuro T; Ohmoto Y; Naito K
    J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of beta-catenin in renal cell carcinoma.
    Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
    Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
    BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma related novel gene, GYLZ-RCC18: cloning and functional studies.
    Zhang Q; Chen L; Liang L; Xi Z; Ding Y; Tong M; Zhang Z; Lee C; Guo Y
    Chin Med J (Engl); 2002 May; 115(5):746-9. PubMed ID: 12133548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study of saponins from Tribulus terrestris on renal carcinoma cell line].
    Yang HJ; Qu WJ; Sun B
    Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1271-4. PubMed ID: 16245908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
    Sun S; Ning X; Liu J; Liu L; Chen Y; Han S; Zhang Y; Liang J; Wu K; Fan D
    Biochem Biophys Res Commun; 2007 May; 356(4):864-71. PubMed ID: 17400182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemosensitization of T-47D breast carcinoma cells to TRAIL and Fas receptor-induced killing.
    Morgan M; Williams BA; Blay J; Hoskin DW
    Anticancer Res; 2002; 22(2A):673-6. PubMed ID: 12014636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of anti-fas ribozyme on apoptosis of mouse T cells.
    Zhang M; Chen ZC; Tian L; Liu F; Liu LB; You Y; Zou P
    Ai Zheng; 2005 May; 24(5):520-4. PubMed ID: 15890090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
    Hemmerlein B; Johanns U; Halbfass J; Böttcher T; Heuser M; Radzun HJ; Thelen P
    Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
    Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
    Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
    Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
    FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
    Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
    J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
    Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.
    Jöhrer K; Zelle-Rieser C; Perathoner A; Moser P; Hager M; Ramoner R; Gander H; Höltl L; Bartsch G; Greil R; Thurnher M
    Clin Cancer Res; 2005 Apr; 11(7):2459-65. PubMed ID: 15814620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.